ATE81290T1 - Zusammensetzungen mit einem gehalt an mikroflora mit erhoehter adhaesion. - Google Patents

Zusammensetzungen mit einem gehalt an mikroflora mit erhoehter adhaesion.

Info

Publication number
ATE81290T1
ATE81290T1 AT85905903T AT85905903T ATE81290T1 AT E81290 T1 ATE81290 T1 AT E81290T1 AT 85905903 T AT85905903 T AT 85905903T AT 85905903 T AT85905903 T AT 85905903T AT E81290 T1 ATE81290 T1 AT E81290T1
Authority
AT
Austria
Prior art keywords
pct
increased
adhaesion
compositions containing
bacteria
Prior art date
Application number
AT85905903T
Other languages
English (en)
Inventor
Patricia Conway
Staffan Kjelleberg
Original Assignee
Chemical Dynamics Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemical Dynamics Sweden Ab filed Critical Chemical Dynamics Sweden Ab
Application granted granted Critical
Publication of ATE81290T1 publication Critical patent/ATE81290T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Feed For Specific Animals (AREA)
AT85905903T 1984-11-08 1985-11-05 Zusammensetzungen mit einem gehalt an mikroflora mit erhoehter adhaesion. ATE81290T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8405587A SE463598B (sv) 1984-11-08 1984-11-08 Preparat, avsett att oeka vidhaeftningen av bakterier till mag-tarmkanalen hos maenniskor och djur, samt ett framstaellningsfoerfarande foer detta
PCT/SE1985/000431 WO1986002837A1 (en) 1984-11-08 1985-11-05 A method of binding microflora and preparations therefor
EP85905903A EP0201579B1 (de) 1984-11-08 1985-11-05 Zusammensetzungen mit einem gehalt an mikroflora mit erhoehter adhaesion

Publications (1)

Publication Number Publication Date
ATE81290T1 true ATE81290T1 (de) 1992-10-15

Family

ID=20357659

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85905903T ATE81290T1 (de) 1984-11-08 1985-11-05 Zusammensetzungen mit einem gehalt an mikroflora mit erhoehter adhaesion.

Country Status (11)

Country Link
US (1) US4767623A (de)
EP (1) EP0201579B1 (de)
JP (1) JPH0720876B2 (de)
AT (1) ATE81290T1 (de)
CA (1) CA1266234A (de)
DE (1) DE3586744T2 (de)
DK (1) DK172252B1 (de)
ES (2) ES8700938A1 (de)
FI (1) FI85810C (de)
SE (1) SE463598B (de)
WO (1) WO1986002837A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
SE8900546D0 (sv) * 1989-02-17 1989-02-17 Bioinvent Int Ab Medel foer inhibering av patogeners adhesion tillvaext och /eller oeverlevnad
IL101410A0 (en) * 1992-03-29 1992-11-15 Era Masis Ltd Formulation for the treatment of cancer
AUPM823094A0 (en) * 1994-09-16 1994-10-13 Goodman Fielder Limited Probiotic compositions
WO1998030235A1 (en) * 1997-01-09 1998-07-16 Morinaga Milk Industry Co., Ltd. Lactoferrin tablets
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
CN1304313A (zh) * 1998-06-05 2001-07-18 若素制药株式会社 含乳酸菌的组合物、药物和食物
ATE319459T1 (de) * 1998-11-26 2006-03-15 Meito Sangyo Kk Bakteriostatische zusammensetzungen für salmonella
RU2229827C2 (ru) * 2002-04-30 2004-06-10 Государственное научное учреждение Всероссийский научно-исследовательский институт физиологии, биохимии и питания сельскохозяйственных животных Способ повышения продуктивности сельскохозяйственных животных и улучшения качества продукции
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
EP1871868A2 (de) * 2005-04-15 2008-01-02 North Carolina State University Verfahren und zusammensetzungen zur modulation des haftvermögens und der stresstoleranz bei bakterien
AU2006253007B2 (en) * 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
EP2261323A1 (de) * 2005-05-31 2010-12-15 The Iams Company Probiotische Katzen-Laktobazillen
RU2436581C2 (ru) 2007-02-01 2011-12-20 Дзе Иамс Компани Способ уменьшения воспаления и снижения стресса у млекопитающего
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL294835A (de) * 1962-07-19 1900-01-01
SE371209B (de) * 1969-10-13 1974-11-11 Cernelle Ab
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
DE2738652C3 (de) * 1977-08-26 1981-02-19 Seiken Kai Foundation Juridical Person, Tondabayashi, Osaka (Japan) Lactobacillus-Präparat und seine Verwendung bei der Bekämpfung bakterieller Infektionen und Entzündungen
CH637297A5 (fr) * 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
JPS5810520A (ja) * 1981-07-10 1983-01-21 Miyarisan Kk 胆石症の治療薬
JPS5911177A (ja) * 1982-07-12 1984-01-20 Seikenkai 新規乳酸桿菌
SE8206250L (sv) * 1982-11-03 1984-05-04 Chemical Dynamics Sweden Ab Reglering av tarmmikroflora

Also Published As

Publication number Publication date
DE3586744T2 (de) 1993-04-01
SE8405587L (sv) 1986-05-09
DK325486A (da) 1986-07-08
WO1986002837A1 (en) 1986-05-22
DK172252B1 (da) 1998-02-09
SE8405587D0 (sv) 1984-11-08
FI862863A0 (fi) 1986-07-07
DK325486D0 (da) 1986-07-08
ES549313A0 (es) 1986-11-16
FI85810C (fi) 1992-06-10
EP0201579B1 (de) 1992-10-07
ES8700938A1 (es) 1986-11-16
JPS62500722A (ja) 1987-03-26
CA1266234A (en) 1990-02-27
AU5097285A (en) 1986-06-03
AU589384B2 (en) 1989-10-12
FI862863L (fi) 1986-07-07
JPH0720876B2 (ja) 1995-03-08
EP0201579A1 (de) 1986-11-20
SE463598B (sv) 1990-12-17
FI85810B (fi) 1992-02-28
US4767623A (en) 1988-08-30
DE3586744D1 (de) 1992-11-12
ES8705229A1 (es) 1987-05-16
ES557029A0 (es) 1987-05-16

Similar Documents

Publication Publication Date Title
ATE81290T1 (de) Zusammensetzungen mit einem gehalt an mikroflora mit erhoehter adhaesion.
ATE73658T1 (de) Diaetzusatz zur verminderung der gefahr einer infektion.
ATE126972T1 (de) Formulierung zur behandlung von silage.
ATE110531T1 (de) Hochsaures system enthaltende nahrungsformulierungen.
CA1268123C (en) DIETARY PRODUCTS CONTAINING METHYLSULFONYLMETHANE AND THEIR USE
ZA871178B (en) Spreads having a good microbiological stability and a fresh dairy taste
DE69429297D1 (de) Zusammensetzung zur Behandlung von Patienten mit Lebererkrankungen
ATE95060T1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
BR9506881A (pt) Composição alimentar do tipo comportando um biscoito ou uma casca de chocolate e um recheio à base de produto lácteo recheio utilizável na mesma e barra achocolatada
DE3588023D1 (de) Mittel zur Behandlung von Herzerkrankungen.
ATE272321T1 (de) Modifizierte fettmischungen
DK317988D0 (da) Fremgangsmaade og praeparat til oegning af proteinindholdet i maelk i maelkeproducerende dyr
FR2581310B1 (fr) Composition therapeutique comportant de l'acide a-linolenique et un compose susceptible de favoriser le passage de l'acide au travers de la membrane cellulaire et extrait de plantes comprenant l'acide et le compose
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
ATE114933T1 (de) Nährungszusammensetzung und verfahren zu ihrer herstellung.
IT8483359A0 (it) Procedimento per ottenere lapreparazione di concentrati e nutrimenti proteici dal sangue animale.
NO164719C (no) Fremgangsmaate for fremstilling av glucopeptider og anvendelse av disse.
DE69530419D1 (de) Saccharomyces-behandlung zur verringerung von campylobakter- und salmonella-populationen in geflügel
ES8207416A1 (es) Procedimiento para preparar un sucedaneo de polen alimenti- cio utilizable en apicultura
EP0246223A4 (de) Produktionssteigerungs- und stimulierungsmittel für mikrobielle pflanzen.
MY100892A (en) Veterinary preparations.
FI861345A7 (fi) Efomysiinien käyttö tuotannon edistämiseksi eläimillä, efomysiinejä ja niiden valmistus.
ATE42201T1 (de) Verwendung von phytosterolglycosiden zur herstellung von arzneimitteln zur behandlung von erhoehtem 5(6)alpha-epoxycholesterolgehalt.
BG60542B2 (en) Water soluble composition having coccidiostatic effect
Lipner Physiological considerations of the relative specificity of dental caries in man